T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
United Parks & Resorts
PRKS
$2.79B
| $11.4M | ﹤0.01% |
242,595
+1,290
| +0.5% | +$60.8K |
|
|
BBOT
1077
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$823M
| $11.4M | ﹤0.01% |
1,071,550
| – | – |
|
|
PARA
1078
DELISTED
Paramount Global Class B
PARA
| $11.4M | ﹤0.01% |
881,325
-15,623
| -2% | -$202K |
|
1079
Match Group
MTCH
$9.08B
| $11.3M | ﹤0.01% |
365,982
-2,496
| -0.7% | -$77.1K |
|
1080
Charles River Laboratories
CRL
$7.52B
| $11.3M | ﹤0.01% |
74,470
-1,498
| -2% | -$227K |
|
1081
MGM Resorts International
MGM
$9.4B
| $11.2M | ﹤0.01% |
327,060
-17,350
| -5% | -$597K |
|
1082
WillScot Mobile Mini Holdings
WSC
$4.19B
| $11.2M | ﹤0.01% |
406,916
-2,643,135
| -87% | -$72.4M |
|
1083
Glaukos
GKOS
$4.75B
| $11.1M | ﹤0.01% |
107,542
+69,777
| +185% | +$7.21M |
|
1084
Fidelity National Financial
FNF
$16.4B
| $11.1M | ﹤0.01% |
197,612
+7,591
| +4% | +$426K |
|
1085
Seadrill
SDRL
$2.04B
| $11M | ﹤0.01% |
419,261
+14,876
| +4% | +$391K |
|
1086
Lyft
LYFT
$7.73B
| $10.8M | ﹤0.01% |
685,750
-183,919
| -21% | -$2.9M |
|
1087
Corcept Therapeutics
CORT
$7.68B
| $10.8M | ﹤0.01% |
147,092
+82,200
| +127% | +$6.03M |
|
1088
AES
AES
$9.17B
| $10.8M | ﹤0.01% |
1,025,775
-19,791
| -2% | -$208K |
|
1089
AngloGold Ashanti
AU
$33.5B
| $10.8M | ﹤0.01% |
236,165
+188,156
| +392% | +$8.58M |
|
1090
Graco
GGG
$14B
| $10.7M | ﹤0.01% |
124,567
+3,106
| +3% | +$267K |
|
1091
Franklin Resources
BEN
$12.8B
| $10.7M | ﹤0.01% |
448,535
-134
| -0% | -$3.2K |
|
1092
Enliven Therapeutics
ELVN
$1.18B
| $10.6M | ﹤0.01% |
528,250
+512,090
| +3,169% | +$10.3M |
|
1093
Albemarle
ALB
$8.94B
| $10.4M | ﹤0.01% |
165,525
+366
| +0.2% | +$22.9K |
|
1094
Chemed
CHE
$6.5B
| $10.3M | ﹤0.01% |
21,241
-1,583
| -7% | -$771K |
|
1095
KBR
KBR
$6.36B
| $10.3M | ﹤0.01% |
215,280
-2,514
| -1% | -$121K |
|
1096
Joby Aviation
JOBY
$12B
| $10.3M | ﹤0.01% |
972,373
+605,182
| +165% | +$6.38M |
|
|
BCYC
1097
Bicycle Therapeutics
BCYC
$490M
| $10.2M | ﹤0.01% |
1,468,393
-68,191
| -4% | -$474K |
|
1098
Fulton Financial
FULT
$3.54B
| $10.2M | ﹤0.01% |
563,776
+53,121
| +10% | +$958K |
|
1099
TD Synnex
SNX
$12.5B
| $10.2M | ﹤0.01% |
74,870
+3,113
| +4% | +$422K |
|
1100
iShares Core S&P 500 ETF
IVV
$675B
| $10.1M | ﹤0.01% |
16,341
-20,678
| -56% | -$12.8M |
|